ARF Function Does Not Require p53 Stabilization or Mdm2 Relocalization
Open Access
- 1 January 2002
- journal article
- research article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 22 (1) , 196-206
- https://doi.org/10.1128/mcb.22.1.196-206.2002
Abstract
It is generally accepted that the ARF tumor suppressor induces p53-dependent growth arrest by sequestering the p53 antagonist Mdm2 in the nucleolus. Previous mutagenic studies of murine ARF suggested that residues 1 through 14 and 26 through 37 were critical for Mdm2 binding, while the latter domain also governed ARF nucleolar localization. We show that mouse ARF residues 6 to 10 and 21 to 25 are required for ARF-induced growth arrest whereas residues 1 to 5 and 29 to 34 are dispensable. Deletion of the putative nucleolar localization signal 31RRPR34 did not prevent nucleolar localization. Surprisingly, unlike wild-type ARF, growth-inhibitory mutants D1-5 and D29-34 failed to stabilize p53 yet induced its transcriptional activation in reporter assays. This suggests that p53 stabilization is not essential for ARF-mediated activation of p53. Like wild-type ARF, both mutants also exhibited p53-independent function since they were able to arrest p53/Mdm2-null cells. Notably, other mutants lacking conserved residues 6 to 10 or 21 to 25 were unable to suppress growth in p53-positive cells despite nucleolar localization and the ability to import Mdm2. Those observations stood in apparent contrast to the ability of wild-type ARF to block growth in some cells without relocalizing endogenous Mdm2 to nucleoli. Together, these data show a lack of correlation between ARF activity and Mdm2 relocalization, suggesting that additional events other than Mdm2 import are required for ARF function.Keywords
This publication has 66 references indexed in Scilit:
- Human ARF protein interacts with Topoisomerase I and stimulates its activityOncogene, 2001
- Solution Structure of the p53 Regulatory Domain of the p19Arf Tumor Suppressor ProteinBiochemistry, 2001
- Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localizationOncogene, 2000
- An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivoOncogene, 2000
- Immunolocalization of Human p14ARF to the Granular Component of the Interphase NucleolusExperimental Cell Research, 2000
- Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53The EMBO Journal, 1999
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53Nature, 1993